Aminocaproic acid 0.25 GM/mL Oral Solution
RxNorm 582299
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 582299 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aminocaproic acid 0.25 GM/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
6-aminocaproic acid 250 mg/ML Oral Solution
(Atom ID: 12328797)
SYPrescribable
Synonym (SY):
6-aminocaproic acid 0.25 GM per mL Oral Syrup
(Atom ID: 4661781)
SYPrescribable
Synonym (SY):
6-aminocaproic acid 1.25 GM per 5 mL Oral Syrup
(Atom ID: 3753708)
PSNPrescribable
Prescribable Name (PSN):
Aminocaproic acid 0.25 GM/mL Oral Solution
(Atom ID: 7255684)
PTPrescribable
Designated preferred name (PT):
Aminocaproic acid 250 mg/mL oral solution
(Atom ID: 11435186)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely aminocaproic acid 250 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 11439149)
Patient Education
Aminocaproic Acid
Aminocaproic acid is used to control bleeding that occurs when blood clots are broken down too quickly. This type of bleeding may occur during or after heart or liver surgery; in people who have certain bleeding disorders; in people who have cancer of the prostate (a male reproductive gland), lung, stomach, or cervix (opening of the uterus); and in pregnant women experiencing placental abruption (placenta separates from the uterus before the baby is ready to be born). Aminocaproic acid is also used to control bleeding in the urinary tract (the organs in the body that produce and excrete urine) that may occur after prostate or kidney surgery or in people who have certain types of cancer. Aminocaproic acid should not be used to treat bleeding that is not caused by faster than normal clot breakdown, so your doctor may order tests to find the cause of your bleeding before you begin your treatment. Aminocaproic acid is in a class of medications called hemostatics. It works by slowing the breakdown of blood clots.
[Learn More]
* Please review the disclaimer below.